drugset
drugset / Trial / NCT05991375

Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine

NCT05991375 ↗

Phase 4 Completed 108 enrolled Sindh Institute of Urology and Transplantation
RandomizedParallel-groupDouble-blindTreatment

Summary

End-stage renal disease (ESRD) patients are coming for Brachial vein transposition surgery. Patients were randomly allocated using sealed opaque envelope bearing A- (Injection bupivacaine (0.25%) 28 ml plus 2 ml. normal saline) and B-Injection bupivacaine (0.25%) 28 mL plus dexmedetomidine I ug/kg diluted to 2 ml). Supraclavicular block under ultrasound and nerve stimulator guidance was performed.

Timeline

Start
2021-02-15
Primary completion
2021-04-30
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg —

Indications

No indication recorded.